Semaglutide: Side Effects, Risks, and Long-Term Considerations
Semaglutide, initially developed for type 2 diabetes, is a GLP-1 receptor agonist that has gained attention in weight management and fitness. It aids in blood sugar control by stimulating insulin and suppressing glucagon, also reducing appetite. Its potential in fitness is notable for weight control but should complement disciplined exercise and diet. Always seek medical guidance.

